Inhibition of TYK2 attenuates hyper IL-6- and Oncostatin M-mediated Calcium Signalling in Sensory Neurons
American Journal of Physiology-Cell Physiology · 02.11.2026
DOI: 10.1152/ajpcell.90084.2026 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Physiology-Cell Physiology, online erschienen am 02.11.2026. Verfasst von Thomas Pritchard und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, University of Cambridge, Cambridge, United Kingdom. Gefördert von: Crohn’s and Colitis Foundation.
Abstract (Originalsprache)
Inflammatory bowel disease (IBD) is characterised by chronic pain, a debilitating symptom for which effective treatments are few and far between. IBD pathogenesis includes the prevalence of a variety of pro-inflammatory cytokines, including the Interleukin-6 (IL-6) family members Il-6 and Oncostatin M (OSM). Previous research has shown disruption of OSM signaling can modulate nociceptor sensitization and activation, however the downstream signalling pathway is unknown. When an in silico analysis of murine colonic sensory neuronal populations was undertaken for receptor expression for OSM and other factors necessary for intracellular signaling, we can find diverse expression indicative of functional signaling. We were able to observe that hyper Il-6 (Il-6 bound to the soluble Il-6 receptor) and OSM can elicit activation of a subset of murine sensory neurons by finding an increase in calcium mobilization following superfusion. This could then be attenuated by the pharmacologic inhibition of all janus kinases or interestingly, TYK2 alone. Furthermore, inhibition of transient receptor potential vanilloid 1 or transient receptor potential ankyrin 1 ion channels, which are known to be sensitized by OSM in other sensory neurons, also reduced the proportion of OSM-responsive neurons. This further understanding of OSM signaling in sensory neurons creates avenues for more extensive research into the molecular mechanisms occurring as well as the potential to exploit these therapeutically to induce analgesia in a subset of neurons.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacology, University of Cambridge, Cambridge, United Kingdom.
- Blizard Institute, Wingate Institute of Neurogastroenterology, Centre for Neuroscience, Surgery and Trauma, Barts and the London School of Medicine and Dentistry, Queen Mary University, London, United Kingdom.
ORCID-Profile: Thomas Pritchard, Rohit Gupta, Kyara De Oliveira Taborda, James P Higham, David C Bulmer
Förderung
- Crohn’s and Colitis Foundation
Zitieren
APA
Pritchard, T., Gupta, R., Taborda, K. O., Higham, J. P., Aziz, Q., & Bulmer, D. C. (2026). Inhibition of TYK2 attenuates hyper IL-6- and Oncostatin M-mediated Calcium Signalling in Sensory Neurons. American Journal of Physiology-Cell Physiology. https://doi.org/10.1152/ajpcell.90084.2026
Vancouver
Pritchard T, Gupta R, Taborda KO, Higham JP, Aziz Q, Bulmer DC. Inhibition of TYK2 attenuates hyper IL-6- and Oncostatin M-mediated Calcium Signalling in Sensory Neurons. American Journal of Physiology-Cell Physiology. 2026. doi:10.1152/ajpcell.90084.2026
BibTeX
@article{Pritchard2026,
author = {Pritchard, Thomas and Gupta, Rohit and Taborda, Kyara De Oliveira and Higham, James P and Aziz, Qasim and Bulmer, David C},
title = {Inhibition of TYK2 attenuates hyper IL-6- and Oncostatin M-mediated Calcium Signalling in Sensory Neurons},
journal = {American Journal of Physiology-Cell Physiology},
year = {2026},
doi = {10.1152/ajpcell.90084.2026}
}
EUVIMED